BIRMINGHAM, Ala.--()--BioHorizons, a dental implant company, announces the launch of MinerOss® Cancellous, a mineralized cancellous bone allograft for periodontal defects, extraction sockets, grafting for implant placement, and ridge and sinus augmentation. The addition of MinerOss Cancellous increases the number of bone grafting options in the MinerOss family, offering clinicians a variety of solutions.
“MinerOss Cancellous is an outstanding choice for particulate grafting”
“MinerOss Cancellous is an outstanding choice for particulate grafting,” said Dr. Bach Le, DDS, MD, FICD, FACD, Los Angeles, CA. “Its exceptional handling and predictable results have proven to be an asset in my practice.”
The cancellous allograft ranges in size from 300 to 1,000 microns providing ideal handling characteristics for a wide variety of regenerative procedures. MinerOss Cancellous is readily available in 0.5cc, 1.0cc, and 2.5cc easy-to-use vials with a screw-top lid. The osteoconductive properties along with the fast remodeling time of MinerOss Cancellous promote rapid revascularization and predictable results.
“With the addition of MinerOss Cancellous to the BioHorizons portfolio, dental implant professionals now have a variety of biologic choices to suit the clinical requirements for their patients,” said Steve Boggan, President and CEO of BioHorizons.
About BioHorizons - BioHorizons, Inc. is a fast growing implant and biologics company in the dental implant industry. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit www.biohorizons.com.
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
Email 